The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001223325
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
14/09/2026
Date registered
Help: Date registered
7/10/2026
Date last updated
Help: Date last updated
7/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
7/10/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
The effects of high fat diet on blood concentration of soluble B-amyloid
Scientific title
Interactive Effects of Dietary Fat and APOE Genotype on Peripheral Amyloid-Beta: Implications for Alzheimer’s Disease Risk in Healthy Adults aged 19 to 69 Years
Additional trial identifiers [1] 318391 0
nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Alzhiemers disease 343532 0
Condition category
Condition code
Neurological 339640 339640 0 0
Alzheimer's disease

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
This study was developed as a randomised single-blind crossover trial. Each subject was given 20 minutes to consume meals rich in either saturated fatty acids (SFA), unsaturated fatty acids (UFA) or no added fat (NF) on three separate days. Blood samples were taken over an eight-hour period to observe the dietary effect on postprandial plasma lip and Ab concentrations. The three meal challenges took place on separate visits, with two weeks between visits. Participants received the meals in a randomised crossover sequence.

The intervention meals comprised of 80 grams of regular uncooked San Remo brand penne pasta which was cooked per packet instructions and 175 grams of generic pasta sauce was added on top of the pasta once plated by the clinical team. The meals were then spiked with either SFA in the form of cocoa butter, UFA in the form of safflower oil or no fat added.
1. Saturated Fatty Acid meal – cocoa butter
2. Unsaturated Fatty Acid meal – safflower oil
3. Control meal - no added fat

All participants were supervised by research staff to ensure compliance. After the meal, the participants would stay in the clinic for a period of 8 hours where they would undergo a blood collection at baseline, 3hr, 5hr and 8hr post meal timepoints.
Intervention code [1] 335286 0
Prevention
Description of the comparator or control
The study was developed as a randomised single-blind crossover human trial. As a crossover trial, participants would undertake all interventions, allowing participants to act as their own control. This would allow for comparisons between interventions within an individual. The control meal within this trial is the meal containing no fat.
Control group
Active

Outcomes
Primary outcome [1] 346813 0
Plasma triglyceride concentration
Timepoint [1] 346813 0
Baseline, 3hr, 5hr and 8hr timepoints during Visit 1, Visit 2 and Visit 3
Primary outcome [2] 346814 0
Plasma apolipoprotein B48 concentration
Timepoint [2] 346814 0
Baseline, 3hr, 5hr and 8hr timepoints during Visit 1, Visit 2 and Visit 3
Primary outcome [3] 346815 0
Plasma Aß1–40 concentration
Timepoint [3] 346815 0
Baseline, 3hr, 5hr and 8hr timepoints during Visit 1, Visit 2 and Visit 3
Secondary outcome [1] 467667 0
Plasma Aß1–42 concentration
Timepoint [1] 467667 0
Baseline, 3hr, 5hr and 8hr timepoints during Visit 1, Visit 2 and Visit 3

Eligibility
Key inclusion criteria
Participants who are between the ages of 19 and 69 who do not meet any of the listed exclusion criteria will be included within the trial.
Minimum age
19 Years
Maximum age
69 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
The exclusion criteria for this study were pregnancy, in lactation, smoking, excess alcohol intake (>2 Australian standard drink/day), use of lipid lowering medication, 40 prior cardiovascular, hepatic or renal disease, > ±5 kg weight change in the previous 6 months, have intention for losing weight in the next 6 months, on dietary advice, taking dietary supplements (e.g. fish oil), history or current use of glucocorticosteroids, insulin and/or thiazolidinediones, gastric disturbances, and younger than 20 or older than 80 years old.

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The intervention meals were prepared by the clinical team in a separate room. The meals were then provided to participants in a manner that did not reveal which intervention they had received.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Participants were randomised through computer generated random allocation for the order of the intervention meals.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
The sample size was calculated based on detecting a 25% effect size, with an alpha level of 0.05 and 80% power, resulting in a required sample size of 45 participants.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA
Recruitment hospital [1] 30195 0
Curtin Health Innovation Research Institute - Curtin University
Recruitment postcode(s) [1] 46590 0
6102 - Curtin University

Funding & Sponsors
Funding source category [1] 322968 0
Government body
Name [1] 322968 0
Australian Government Research Training Program (RTP) Scholarship.
Country [1] 322968 0
Australia
Primary sponsor type
University
Name
Curtin University
Address
Country
Australia
Secondary sponsor category [1] 325893 0
None
Name [1] 325893 0
Address [1] 325893 0
Country [1] 325893 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321379 0
Curtin University Human Research Ethics Committee
Ethics committee address [1] 321379 0
Ethics committee country [1] 321379 0
Australia
Date submitted for ethics approval [1] 321379 0
15/05/2018
Approval date [1] 321379 0
19/07/2018
Ethics approval number [1] 321379 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 153546 0
Mr John Mamo
Address 153546 0
Curtin University, Building 305, Kent street, Bentley, Western Australia, 6102
Country 153546 0
Australia
Phone 153546 0
+61 8 9266 7232
Fax 153546 0
Email 153546 0
Contact person for public queries
Name 153547 0
John Mamo
Address 153547 0
Curtin University, Building 305, Kent street, Bentley, Western Australia, 6102
Country 153547 0
Australia
Phone 153547 0
+61 8 9266 7232
Fax 153547 0
Email 153547 0
Contact person for scientific queries
Name 153548 0
John Mamo
Address 153548 0
Curtin University, Building 305, Kent street, Bentley, Western Australia, 6102
Country 153548 0
Australia
Phone 153548 0
+61 8 9266 7232
Fax 153548 0
Email 153548 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.